BACKGROUND: The National Health Service (NHS) Health Check Programme aims to identify and manage patients in England aged 40-74 years with a 10-year cardiovascular disease (CVD) risk score over 20%. We aimed to assess the prevalence of high CVD risk in the English population, using the two CVD risk scores and the 20% cut off mandated in national policy, and the prevalence of risk factors within this population. DESIGN: Modelling study using patients registered in general practice in England. METHODS: Using data from the Health Survey for England, we modelled the prevalence of high CVD risk in general practice populations. RESULTS: Of those eligible for an NHS Health Check, 10.5% (2,012,000) had a risk score greater than 20% using the QRISK2 risk score; 22.0% (4,267,000) using Joint British Societies' (JBS2) score. There was a median of 206 (range 0-1693) and 447 (0-3321) patients per practice at high risk respectively, with wide geographic variation. Within the high-risk population, there was a high prevalence of CVD risk factors; in the QRISK2 population, for example 82.6% were physically inactive. To reduce risk in those at high CVD risk, we estimate the total costs of the Programme to be £176 million using QRISK2 or £378 million using JBS2. CONCLUSIONS: A large number of high-risk patients will be identified by the Programme; health service commissioners must ensure the adequate provision and the targeted allocation of risk reduction services for the Programme to be effective. The NHS must consider whether extra costs using JBS2 are warranted. The Programme must be fully monitored to ensure its cost effectiveness and appropriate outcomes such as the numbers at high risk assessed.
BACKGROUND: The National Health Service (NHS) Health Check Programme aims to identify and manage patients in England aged 40-74 years with a 10-year cardiovascular disease (CVD) risk score over 20%. We aimed to assess the prevalence of high CVD risk in the English population, using the two CVD risk scores and the 20% cut off mandated in national policy, and the prevalence of risk factors within this population. DESIGN: Modelling study using patients registered in general practice in England. METHODS: Using data from the Health Survey for England, we modelled the prevalence of high CVD risk in general practice populations. RESULTS: Of those eligible for an NHS Health Check, 10.5% (2,012,000) had a risk score greater than 20% using the QRISK2 risk score; 22.0% (4,267,000) using Joint British Societies' (JBS2) score. There was a median of 206 (range 0-1693) and 447 (0-3321) patients per practice at high risk respectively, with wide geographic variation. Within the high-risk population, there was a high prevalence of CVD risk factors; in the QRISK2 population, for example 82.6% were physically inactive. To reduce risk in those at high CVD risk, we estimate the total costs of the Programme to be £176 million using QRISK2 or £378 million using JBS2. CONCLUSIONS: A large number of high-risk patients will be identified by the Programme; health service commissioners must ensure the adequate provision and the targeted allocation of risk reduction services for the Programme to be effective. The NHS must consider whether extra costs using JBS2 are warranted. The Programme must be fully monitored to ensure its cost effectiveness and appropriate outcomes such as the numbers at high risk assessed.
Authors: Alice S Forster; Hiten Dodhia; Helen Booth; Alex Dregan; Frances Fuller; Jane Miller; Caroline Burgess; Lisa McDermott; Martin C Gulliford Journal: J Public Health (Oxf) Date: 2014-10-17 Impact factor: 2.341
Authors: Valery L Feigin; Bo Norrving; Mary G George; Jennifer L Foltz; Gregory A Roth; George A Mensah Journal: Nat Rev Neurol Date: 2016-07-22 Impact factor: 42.937
Authors: Virginia Becerra; Alfredo Gracia; Kamal Desai; Seye Abogunrin; Sarah Brand; Ruth Chapman; Fernando García Alonso; Valentín Fuster; Ginés Sanz Journal: BMJ Open Date: 2015-05-09 Impact factor: 2.692
Authors: Kamlesh Khunti; Danielle H Morris; Claire L Weston; Laura J Gray; David R Webb; Melanie J Davies Journal: PLoS One Date: 2013-01-30 Impact factor: 3.240
Authors: Priya Parmar; Rita Krishnamurthi; M Arfan Ikram; Albert Hofman; Saira S Mirza; Yury Varakin; Michael Kravchenko; Michael Piradov; Amanda G Thrift; Bo Norrving; Wenzhi Wang; Dipes Kumar Mandal; Suzanne Barker-Collo; Ramesh Sahathevan; Stephen Davis; Gustavo Saposnik; Miia Kivipelto; Shireen Sindi; Natan M Bornstein; Maurice Giroud; Yannick Béjot; Michael Brainin; Richie Poulton; K M Venkat Narayan; Manuel Correia; António Freire; Yoshihiro Kokubo; David Wiebers; George Mensah; Nasser F BinDhim; P Alan Barber; Jeyaraj Durai Pandian; Graeme J Hankey; Man Mohan Mehndiratta; Shobhana Azhagammal; Norlinah Mohd Ibrahim; Max Abbott; Elaine Rush; Patria Hume; Tasleem Hussein; Rohit Bhattacharjee; Mitali Purohit; Valery L Feigin Journal: Int J Stroke Date: 2014-12-10 Impact factor: 5.266